Egypt explains approval of changes to parenteral biological formulations
This article was originally published in SRA
Executive Summary
The Egyptian Drug Authority has issued final guidance explaining the types of changes to parenteral biological preparations that can be approved as a variation or would require submission of a new drug application1.